{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T06:44:07Z","timestamp":1790837047020,"version":"4.1.0"},"reference-count":78,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2022,7,22]],"date-time":"2022-07-22T00:00:00Z","timestamp":1658448000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,7,22]],"date-time":"2022-07-22T00:00:00Z","timestamp":1658448000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","award":["777460"],"award-info":[{"award-number":["777460"]}],"id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetologia"],"published-print":{"date-parts":[[2022,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aim\/hypothesis<\/jats:title>\n                    <jats:p>The physiological counterregulatory response to hypoglycaemia is reported to be organised hierarchically, with hormone responses usually preceding symptomatic awareness and autonomic responses preceding neuroglycopenic responses. To compare thresholds for activation of these responses more accurately between people with or without type 1 diabetes, we performed a systematic review on stepped hyperinsulinaemic\u2013hypoglycaemic glucose clamps.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A literature search in PubMed and EMBASE was conducted. We included articles published between 1980 and 2018 involving hyperinsulinaemic stepped hypoglycaemic glucose clamps among people with or without type 1 diabetes. Key exclusion criteria were as follows: data were previously published; other patient population; a clamp not the primary intervention; and an inadequate clamp description. Glycaemic thresholds for counterregulatory hormone and\/or symptom responses to hypoglycaemia were estimated and compared using generalised logrank test for interval-censored data, where the intervals were either extracted directly or calculated from the data provided by the study. A glycaemic threshold was defined as the glucose level at which the response exceeded the 95% CI of the mean baseline measurement or euglycaemic control clamp. Because of the use of interval-censored data, we described thresholds using median and IQR.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 63 articles were included, whereof 37 papers included participants with type 1 diabetes (\n                      <jats:italic>n<\/jats:italic>\n                      =559; 67.4% male sex, aged 32.7\u00b110.2 years, BMI 23.8\u00b11.4 kg\/m\n                      <jats:sup>2<\/jats:sup>\n                      ) and 51 papers included participants without diabetes (\n                      <jats:italic>n<\/jats:italic>\n                      =733; 72.4% male sex, aged 31.1\u00b19.2 years, BMI 23.6\u00b11.1 kg\/m\n                      <jats:sup>2<\/jats:sup>\n                      ). Compared with non-diabetic control individuals, in people with type 1 diabetes, the median (IQR) glycaemic thresholds for adrenaline (3.8 [3.2\u20134.2] vs 3.4 [2.8\u20133.9 mmol\/l]), noradrenaline (3.2 [3.2\u20133.7] vs 3.0 [2.8\u20133.1] mmol\/l), cortisol (3.5 [3.2\u20134.2]) vs 2.8 [2.8\u20133.4] mmol\/l) and growth hormone (3.8 [3.3\u20133.8] vs. 3.2 [3.0\u20133.3] mmol\/l) all occurred at lower glucose levels in people with diabetes than in those without diabetes (all\n                      <jats:italic>p<\/jats:italic>\n                      \u22640.01). Similarly, although both autonomic (median [IQR] 3.4 [3.4\u20133.4] vs 3.0 [2.8\u20133.4] mmol\/l) and neuroglycopenic (median [IQR] 3.4 [2.8\u2013N\/A] vs 3.0 [3.0\u20133.1] mmol\/l) symptom responses were elicited at lower glucose levels in people with type 1 diabetes, the thresholds for autonomic and neuroglycopenic symptoms did not differ for each individual subgroup.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions\/interpretation<\/jats:title>\n                    <jats:p>People with type 1 diabetes have glycaemic thresholds for counterregulatory hormone and symptom responses at lower glucose levels than people without diabetes. Autonomic and neuroglycopenic symptoms responses are generated at about similar levels of hypoglycaemia. There was a considerable variation in the methodology of the articles and the high insulin doses in most of the clamps may affect the counterregulatory responses.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Funding<\/jats:title>\n                    <jats:p>This article has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement no. 777460.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Registration<\/jats:title>\n                    <jats:p>This systematic review is registered in PROSPERO (CRD42019120083).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Graphical abstract<\/jats:title>\n                  <\/jats:sec>","DOI":"10.1007\/s00125-022-05749-8","type":"journal-article","created":{"date-parts":[[2022,7,22]],"date-time":"2022-07-22T01:02:31Z","timestamp":1658451751000},"page":"1601-1612","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Glycaemic thresholds for counterregulatory hormone and symptom responses to hypoglycaemia in people with and without type 1 diabetes: a systematic review"],"prefix":"10.1007","volume":"65","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9905-7669","authenticated-orcid":false,"given":"Clementine E. M.","family":"Verhulst","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6344-5408","authenticated-orcid":false,"given":"Therese W.","family":"Fabricius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4103-7451","authenticated-orcid":false,"given":"Steven","family":"Teerenstra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5431-824X","authenticated-orcid":false,"given":"Peter L.","family":"Kristensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0322-1653","authenticated-orcid":false,"given":"Cees J.","family":"Tack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3957-1981","authenticated-orcid":false,"given":"Rory J.","family":"McCrimmon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2425-9565","authenticated-orcid":false,"given":"Simon","family":"Heller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8122-8987","authenticated-orcid":false,"given":"Mark L.","family":"Evans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2686-5531","authenticated-orcid":false,"given":"Stephanie A.","family":"Amiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0588-4880","authenticated-orcid":false,"given":"Ulrik","family":"Pedersen-Bjergaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1255-7741","authenticated-orcid":false,"given":"Bastiaan E.","family":"de Galan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of the Hypo-RESOLVE consortium","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,22]]},"reference":[{"key":"5749_CR1","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.2337\/diacare.26.6.1902","volume":"26","author":"PE Cryer","year":"2003","unstructured":"Cryer PE, Davis SN, Shamoon H (2003) Hypoglycemia in diabetes. Diabetes Care 26:1902\u20131912. https:\/\/doi.org\/10.2337\/diacare.26.6.1902","journal-title":"Diabetes Care"},{"key":"5749_CR2","doi-asserted-by":"publisher","first-page":"9801640","DOI":"10.1155\/2016\/9801640","volume":"2016","author":"M Senthilkumaran","year":"2016","unstructured":"Senthilkumaran M, Zhou XF, Bobrovskaya L (2016) Challenges in Modelling Hypoglycaemia-Associated Autonomic Failure: A Review of Human and Animal Studies. Int J Endocrinol. 2016:9801640. https:\/\/doi.org\/10.1155\/2016\/9801640","journal-title":"Int J Endocrinol."},{"key":"5749_CR3","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/0531-5565(93)90064-K","volume":"28","author":"RS Sherwin","year":"1993","unstructured":"Sherwin RS (1993) Evaluation of hypoglycemic counterregulation using a modification of the Andres glucose clamp. Exp Gerontol 28:371\u2013380. https:\/\/doi.org\/10.1016\/0531-5565(93)90064-K","journal-title":"Exp Gerontol"},{"issue":"4","key":"5749_CR4","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1007\/s00125-020-05361-8","volume":"64","author":"TW Fabricius","year":"2021","unstructured":"Fabricius TW, Verhulst CEM, Kristensen PL et al (2021) Hyperinsulinaemic\u2013hypoglycaemic glucose clamps in human research: a systematic review of the literature. Diabetologia 64(4):727\u2013736. https:\/\/doi.org\/10.1007\/s00125-020-05361-8","journal-title":"Diabetologia"},{"key":"5749_CR5","doi-asserted-by":"publisher","first-page":"2948","DOI":"10.2337\/diacare.28.12.2948","volume":"28","author":"NN Zammitt","year":"2005","unstructured":"Zammitt NN, Frier BM (2005) Hypoglycemia in type 2 diabetes: Pathophysiology, frequency, and effects of different treatment modalities. Diabetes Care 28:2948\u20132961. https:\/\/doi.org\/10.2337\/diacare.28.12.2948","journal-title":"Diabetes Care"},{"key":"5749_CR6","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1172\/JCI116302","volume":"91","author":"SE Dagogo-Jack","year":"1993","unstructured":"Dagogo-Jack SE, Craft S, Cryer PE (1993) Hypoglycemia-associated autonomic failure in insulin-dependent diabetes mellitus. Recent antecedent hypoglycemia reduces autonomic responses to, symptoms of, and defense against subsequent hypoglycemia. J Clin Invest 91:819\u2013828. https:\/\/doi.org\/10.1172\/JCI116302","journal-title":"J Clin Invest"},{"key":"5749_CR7","doi-asserted-by":"publisher","first-page":"912","DOI":"10.4239\/wjd.v6.i7.912","volume":"6","author":"I Mart\u00edn-Tim\u00f3n","year":"2015","unstructured":"Mart\u00edn-Tim\u00f3n I (2015) Mechanisms of hypoglycemia unawareness and implications in diabetic patients. World J Diabetes 6:912. https:\/\/doi.org\/10.4239\/wjd.v6.i7.912","journal-title":"World J Diabetes"},{"key":"5749_CR8","unstructured":"Covidence (2019) Covidence - Better systematic review management. In: Cochrane. https:\/\/www.covidence.org\/home. Accessed 13 Jan 2020"},{"key":"5749_CR9","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1210\/JCEM.87.2.8215","volume":"87","author":"D Dantz","year":"2002","unstructured":"Dantz D, Bewersdorf J, Fruehwald-Schultes B et al (2002) Vascular endothelial growth factor: a novel endocrine defensive response to hypoglycemia. J Clin Endocrinol Metab 87:835\u2013840. https:\/\/doi.org\/10.1210\/JCEM.87.2.8215","journal-title":"J Clin Endocrinol Metab"},{"key":"5749_CR10","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/S0009-9236(03)00093-6","volume":"74","author":"BE De Galan","year":"2003","unstructured":"De Galan BE, Tack CJ, Lenders JW et al (2003) Effect of 2 weeks of theophylline on glucose counterregulation in patients with type 1 diabetes and unawareness of hypoglycemia. Clin Pharmacol Ther 74:77\u201384. https:\/\/doi.org\/10.1016\/S0009-9236(03)00093-6","journal-title":"Clin Pharmacol Ther"},{"key":"5749_CR11","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.2337\/DIACARE.21.11.1960","volume":"21","author":"C Meyer","year":"1998","unstructured":"Meyer C, Gro\u00dfmann R, Mitrakou A et al (1998) Effects of autonomic neuropathy on counterregulation and awareness of hypoglycemia in type 1 diabetic patients. Diabetes Care 21:1960\u20131966. https:\/\/doi.org\/10.2337\/DIACARE.21.11.1960","journal-title":"Diabetes Care"},{"key":"5749_CR12","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1210\/JCEM.86.2.7197","volume":"86","author":"I Gabriely","year":"2001","unstructured":"Gabriely I, Wozniak R, Hawkins M, Shamoon H (2001) Troglitazone amplifies counterregulatory responses to hypoglycemia in nondiabetic subjects. J Clin Endocrinol Metab 86:521\u2013528. https:\/\/doi.org\/10.1210\/JCEM.86.2.7197","journal-title":"J Clin Endocrinol Metab"},{"key":"5749_CR13","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1046\/J.1463-1326.2000.00109.X","volume":"2","author":"S Dagogo-Jack","year":"2000","unstructured":"Dagogo-Jack S, Askari H, Morrill B et al (2000) Physiological responses during hypoglycaemia induced by regular human insulin or a novel human analogue, insulin glargine. Diabetes, Obes Metab 2:373\u2013383. https:\/\/doi.org\/10.1046\/J.1463-1326.2000.00109.X","journal-title":"Diabetes, Obes Metab"},{"key":"5749_CR14","doi-asserted-by":"publisher","first-page":"135","DOI":"10.2337\/diacare.20.2.135","volume":"20","author":"K Matyka","year":"1997","unstructured":"Matyka K, Evans M, Lomas J et al (1997) Altered hierarchy of protective responses against severe hypoglycemia in normal aging in healthy men. Diabetes Care 20:135\u2013141. https:\/\/doi.org\/10.2337\/diacare.20.2.135","journal-title":"Diabetes Care"},{"key":"5749_CR15","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.2337\/DIAB.46.7.1172","volume":"46","author":"C Fanelli","year":"1997","unstructured":"Fanelli C, Pampanelli S, Lalli C et al (1997) Long-term intensive therapy of IDDM patients with clinically overt autonomic neuropathy: effects on hypoglycemia awareness and counterregulation. Diabetes 46:1172\u20131181. https:\/\/doi.org\/10.2337\/DIAB.46.7.1172","journal-title":"Diabetes"},{"key":"5749_CR16","doi-asserted-by":"publisher","first-page":"E67","DOI":"10.1152\/AJPENDO.1991.260.1.E67","volume":"260","author":"A Mitrakou","year":"1991","unstructured":"Mitrakou A, Ryan C, Veneman T et al (1991) Hierarchy of glycemic thresholds for counterregulatory hormone secretion, symptoms, and cerebral dysfunction. Am J Physiol 260:E67\u2013E74. https:\/\/doi.org\/10.1152\/AJPENDO.1991.260.1.E67","journal-title":"Am J Physiol"},{"key":"5749_CR17","doi-asserted-by":"publisher","first-page":"358","DOI":"10.2337\/diab.40.3.358","volume":"40","author":"TW Jones","year":"1991","unstructured":"Jones TW, Boulware SD, Kraemer DT et al (1991) Independent effects of youth and poor diabetes control on responses to hypoglycemia in children. Diabetes 40:358\u2013363. https:\/\/doi.org\/10.2337\/diab.40.3.358","journal-title":"Diabetes"},{"issue":"10","key":"5749_CR18","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1007\/BF00401425","volume":"35","author":"H Vea","year":"1992","unstructured":"Vea H, Jorde R, Sager G et al (1992) Reproducibility of glycaemic thresholds for activation of counterregulatory hormones and hypoglycaemic symptoms in healthy subjects. Diabetologia 35(10):958\u2013961. https:\/\/doi.org\/10.1007\/BF00401425","journal-title":"Diabetologia"},{"key":"5749_CR19","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1172\/JCI112884","volume":"79","author":"NS Schwartz","year":"1987","unstructured":"Schwartz NS, Clutter WE, Shah SD, Cryer PE (1987) Glycemic thresholds for activation of glucose counterregulatory systems are higher than the threshold for symptoms. J Clin Invest 79:777\u2013781. https:\/\/doi.org\/10.1172\/JCI112884","journal-title":"J Clin Invest"},{"key":"5749_CR20","doi-asserted-by":"publisher","first-page":"R8883","DOI":"10.1152\/AJPREGU.1993.265.4.R883","volume":"265","author":"WJ Powers","year":"1993","unstructured":"Powers WJ, Boyle PJ, Hirsch IB, Cryer PE (1993) Unaltered cerebral blood flow during hypoglycemic activation of the sympathochromaffin system in humans. Am J Physiol 265:R8883\u2013R8887. https:\/\/doi.org\/10.1152\/AJPREGU.1993.265.4.R883","journal-title":"Am J Physiol"},{"key":"5749_CR21","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1046\/J.1464-5491.2003.00922.X","volume":"20","author":"E Bingham","year":"2003","unstructured":"Bingham E, Hopkins D, Pernet A et al (2003) The effects of KATP channel modulators on counterregulatory responses and cognitive function during acute controlled hypoglycaemia in healthy men: a pilot study. Diabet Med 20:231\u2013237. https:\/\/doi.org\/10.1046\/J.1464-5491.2003.00922.X","journal-title":"Diabet Med"},{"key":"5749_CR22","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.2337\/DIAB.42.11.1683","volume":"42","author":"CG Fanelli","year":"1993","unstructured":"Fanelli CG, Epifano L, Rambotti AM et al (1993) Meticulous prevention of hypoglycemia normalizes the glycemic thresholds and magnitude of most of neuroendocrine responses to, symptoms of, and cognitive function during hypoglycemia in intensively treated patients with short-term IDDM. Diabetes 42:1683\u20131689. https:\/\/doi.org\/10.2337\/DIAB.42.11.1683","journal-title":"Diabetes"},{"key":"5749_CR23","doi-asserted-by":"publisher","first-page":"183","DOI":"10.2337\/DIACARE.17.3.183","volume":"17","author":"MJ Mellman","year":"1994","unstructured":"Mellman MJ, Davis MR, Brisman M, Shamoon H (1994) Effect of antecedent hypoglycemia on cognitive function and on glycemic thresholds for counterregulatory hormone secretion in healthy humans. Diabetes Care 17:183\u2013188. https:\/\/doi.org\/10.2337\/DIACARE.17.3.183","journal-title":"Diabetes Care"},{"key":"5749_CR24","doi-asserted-by":"publisher","first-page":"403","DOI":"10.2337\/DIAB.43.3.403","volume":"43","author":"GS Meneilly","year":"1994","unstructured":"Meneilly GS, Cheung E, Tuokko H (1994) Counterregulatory hormone responses to hypoglycemia in the elderly patient with diabetes. Diabetes 43:403\u2013410. https:\/\/doi.org\/10.2337\/DIAB.43.3.403","journal-title":"Diabetes"},{"key":"5749_CR25","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1210\/JCEM.78.6.8200936","volume":"78","author":"GS Meneilly","year":"1994","unstructured":"Meneilly GS, Cheung E, Tuokko H (1994) Altered responses to hypoglycemia of healthy elderly people. J Clin Endocrinol Metab 78:1341\u20131348. https:\/\/doi.org\/10.1210\/JCEM.78.6.8200936","journal-title":"J Clin Endocrinol Metab"},{"key":"5749_CR26","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1111\/J.1365-2796.1991.TB00357.X","volume":"229","author":"O Snorgaard","year":"1991","unstructured":"Snorgaard O, Lassen LH, Rosenfalck AM, Binder C (1991) Glycaemic thresholds for hypoglycaemic symptoms, impairment of cognitive function, and release of counterregulatory hormones in subjects with functional hypoglycaemia. J Intern Med 229:343\u2013350. https:\/\/doi.org\/10.1111\/J.1365-2796.1991.TB00357.X","journal-title":"J Intern Med"},{"key":"5749_CR27","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1007\/BF00404337","volume":"37","author":"C Fanelli","year":"1994","unstructured":"Fanelli C, Pampanelli S, Epifano L et al (1994) Relative roles of insulin and hypoglycaemia on induction of neuroendocrine responses to, symptoms of, and deterioration of cognitive function in hypoglycaemia in male and female humans. Diabetologia 37:797\u2013807. https:\/\/doi.org\/10.1007\/BF00404337","journal-title":"Diabetologia"},{"key":"5749_CR28","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/J.PSYNEUEN.2004.12.006","volume":"30","author":"B Schultes","year":"2005","unstructured":"Schultes B, Peters A, Kern W et al (2005) Processing of food stimuli is selectively enhanced during insulin-induced hypoglycemia in healthy men. Psychoneuroendocrinology 30:496\u2013504. https:\/\/doi.org\/10.1016\/J.PSYNEUEN.2004.12.006","journal-title":"Psychoneuroendocrinology"},{"key":"5749_CR29","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1007\/S00125-004-1513-5","volume":"47","author":"D Smith","year":"2004","unstructured":"Smith D, Pernet A, Rosenthal JM et al (2004) The effect of modafinil on counter-regulatory and cognitive responses to hypoglycaemia. Diabetologia 47:1704\u20131711. https:\/\/doi.org\/10.1007\/S00125-004-1513-5","journal-title":"Diabetologia"},{"key":"5749_CR30","doi-asserted-by":"publisher","first-page":"744","DOI":"10.2337\/DIABETES.54.3.744","volume":"54","author":"ML Koivikko","year":"2005","unstructured":"Koivikko ML, Salmela PI, Airaksinen KEJ et al (2005) Effects of sustained insulin-induced hypoglycemia on cardiovascular autonomic regulation in type 1 diabetes. Diabetes 54:744\u2013750. https:\/\/doi.org\/10.2337\/DIABETES.54.3.744","journal-title":"Diabetes"},{"key":"5749_CR31","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1210\/JC.2006-2426","volume":"92","author":"MR Rickels","year":"2007","unstructured":"Rickels MR, Schutta MH, Mueller R et al (2007) Glycemic thresholds for activation of counterregulatory hormone and symptom responses in islet transplant recipients. J Clin Endocrinol Metab 92:873\u2013879. https:\/\/doi.org\/10.1210\/JC.2006-2426","journal-title":"J Clin Endocrinol Metab"},{"key":"5749_CR32","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1007\/BF00399801","volume":"37","author":"C Fanelli","year":"1994","unstructured":"Fanelli C, Pampanelli S, Epifano L et al (1994) Long-term recovery from unawareness, deficient counterregulation and lack of cognitive dysfunction during hypoglycaemia, following institution of rational, intensive insulin therapy in IDDM. Diabetologia 37:1265\u20131276. https:\/\/doi.org\/10.1007\/BF00399801","journal-title":"Diabetologia"},{"key":"5749_CR33","doi-asserted-by":"publisher","first-page":"513","DOI":"10.2337\/DIAB.44.5.513","volume":"44","author":"C Fanelli","year":"1995","unstructured":"Fanelli C, Pampanelli S, Calderone S et al (1995) Effects of recent, short-term hyperglycemia on responses to hypoglycemia in humans. Relevance to the pathogenesis of hypoglycemia unawareness and hyperglycemia-induced insulin resistance. Diabetes 44:513\u2013519. https:\/\/doi.org\/10.2337\/DIAB.44.5.513","journal-title":"Diabetes"},{"key":"5749_CR34","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1093\/OXFORDJOURNALS.QJMED.A069086","volume":"88","author":"EJ Brierley","year":"1995","unstructured":"Brierley EJ, Broughton DL, James OFW, Alberti KGMM (1995) Reduced awareness of hypoglycaemia in the elderly despite an intact counter-regulatory response. QJM An Int J Med 88:439\u2013445. https:\/\/doi.org\/10.1093\/OXFORDJOURNALS.QJMED.A069086","journal-title":"QJM An Int J Med"},{"key":"5749_CR35","doi-asserted-by":"publisher","first-page":"2952","DOI":"10.1210\/JCEM.83.8.4937","volume":"83","author":"ML Evans","year":"1998","unstructured":"Evans ML, Matyka K, Lomas J et al (1998) Reduced counterregulation during hypoglycemia with raised circulating nonglucose lipid substrates: evidence for regional differences in metabolic capacity in the human brain? J Clin Endocrinol Metab 83:2952\u20132959. https:\/\/doi.org\/10.1210\/JCEM.83.8.4937","journal-title":"J Clin Endocrinol Metab"},{"key":"5749_CR36","doi-asserted-by":"publisher","first-page":"9352","DOI":"10.1073\/PNAS.91.20.9352","volume":"91","author":"PJ Boyle","year":"1994","unstructured":"Boyle PJ, Nagy RJ, O\u2019Connor AM et al (1994) Adaptation in brain glucose uptake following recurrent hypoglycemia. Proc Natl Acad Sci U S A 91:9352\u20139356. https:\/\/doi.org\/10.1073\/PNAS.91.20.9352","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5749_CR37","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.2337\/DIACARE.23.8.1059","volume":"23","author":"B Fruehwald-Schultes","year":"2000","unstructured":"Fruehwald-Schultes B, Born J, Kern W et al (2000) Adaptation of cognitive function to hypoglycemia in healthy men. Diabetes Care 23:1059\u20131066. https:\/\/doi.org\/10.2337\/DIACARE.23.8.1059","journal-title":"Diabetes Care"},{"key":"5749_CR38","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/BF00285293","volume":"32","author":"D Kerr","year":"1989","unstructured":"Kerr D, Macdonald IA, Tattersall RB (1989) Adaptation to mild hypoglycaemia in normal subjects despite sustained increases in counter-regulatory hormones. Diabetologia 32:249\u2013254. https:\/\/doi.org\/10.1007\/BF00285293","journal-title":"Diabetologia"},{"key":"5749_CR39","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/S0002-9343(99)80077-1","volume":"98","author":"K Weinger","year":"1995","unstructured":"Weinger K, Jacobson AM, Draelos MT et al (1995) Blood glucose estimation and symptoms during hyperglycemia and hypoglycemia in patients with insulin-dependent diabetes mellitus. Am J Med 98:22\u201331. https:\/\/doi.org\/10.1016\/S0002-9343(99)80077-1","journal-title":"Am J Med"},{"key":"5749_CR40","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1007\/S001250051371","volume":"43","author":"A Maran","year":"2000","unstructured":"Maran A, Crepaldi C, Trupiani S et al (2000) Brain function rescue effect of lactate following hypoglycaemia is not an adaptation process in both normal and type I diabetic subjects. Diabetologia 43:733\u2013741. https:\/\/doi.org\/10.1007\/S001250051371","journal-title":"Diabetologia"},{"key":"5749_CR41","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1007\/s11011-017-0041-1","volume":"32","author":"A Maran","year":"2017","unstructured":"Maran A, Crepaldi C, Del Piccolo F et al (2017) Cognitive, neurophysiologic and metabolic sequelae of previous hypoglycemic coma revealed by hyperinsulinemic-hypoglycemic clamp in type 1 diabetic patients. Metab Brain Dis 32:1543\u20131551. https:\/\/doi.org\/10.1007\/s11011-017-0041-1","journal-title":"Metab Brain Dis"},{"key":"5749_CR42","doi-asserted-by":"publisher","first-page":"17","DOI":"10.2337\/DIACARE.18.1.17","volume":"18","author":"BT Kinsley","year":"1995","unstructured":"Kinsley BT, Widom B, Simonson DC (1995) Differential regulation of counterregulatory hormone secretion and symptoms during hypoglycemia in IDDM. Effect of glycemic control. Diabetes Care 18:17\u201326. https:\/\/doi.org\/10.2337\/DIACARE.18.1.17","journal-title":"Diabetes Care"},{"key":"5749_CR43","doi-asserted-by":"publisher","first-page":"109","DOI":"10.2337\/DIACARE.14.2.109","volume":"14","author":"SA Amiel","year":"1991","unstructured":"Amiel SA, Pottinger RC, Archibald HR et al (1991) Effect of antecedent glucose control on cerebral function during hypoglycemia. Diabetes Care 14:109\u2013118. https:\/\/doi.org\/10.2337\/DIACARE.14.2.109","journal-title":"Diabetes Care"},{"key":"5749_CR44","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1055\/S-2007-993143","volume":"116","author":"N Hermanns","year":"2008","unstructured":"Hermanns N, Plate M, Kulzer B et al (2008) Effect of experimentally induced hypoglycemia and different insulin levels on feelings of hunger in type 1 diabetic patients. Exp Clin Endocrinol Diabetes 116:255\u2013261. https:\/\/doi.org\/10.1055\/S-2007-993143","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"5749_CR45","doi-asserted-by":"publisher","first-page":"901","DOI":"10.2337\/diab.37.7.901","volume":"37","author":"SA Amiel","year":"1988","unstructured":"Amiel SA, Sherwin RS, Simonson DC, Tamborlane WV (1988) Effect of intensive insulin therapy on glycemic thresholds for counterregulatory hormone release. Diabetes 37:901\u2013907. https:\/\/doi.org\/10.2337\/diab.37.7.901","journal-title":"Diabetes"},{"key":"5749_CR46","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1210\/JCEM.81.2.8636289","volume":"81","author":"BT Kinsley","year":"1996","unstructured":"Kinsley BT, Simonson DC (1996) Evidence for a hypothalamic-pituitary versus adrenal cortical effect of glycemic control on counterregulatory hormone responses to hypoglycemia in insulin-dependent diabetes mellitus. J Clin Endocrinol Metab 81:684\u2013691. https:\/\/doi.org\/10.1210\/JCEM.81.2.8636289","journal-title":"J Clin Endocrinol Metab"},{"key":"5749_CR47","doi-asserted-by":"publisher","first-page":"893","DOI":"10.2337\/DIABETES.51.4.893","volume":"51","author":"I Gabriely","year":"2002","unstructured":"Gabriely I, Hawkins M, Vilcu C et al (2002) Fructose amplifies counterregulatory responses to hypoglycemia in humans. Diabetes 51:893\u2013900. https:\/\/doi.org\/10.2337\/DIABETES.51.4.893","journal-title":"Diabetes"},{"key":"5749_CR48","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/S1043-4666(03)00113-3","volume":"22","author":"BE De Galan","year":"2003","unstructured":"De Galan BE, Netea MG, Smits P, Van Der Meer JWM (2003) Hypoglycaemia downregulates endotoxin-induced production of tumour necrosis factor-alpha, but does not affect IL-1beta, IL-6, or IL-10. Cytokine 22:71\u201376. https:\/\/doi.org\/10.1016\/S1043-4666(03)00113-3","journal-title":"Cytokine"},{"key":"5749_CR49","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.2337\/DIACARE.17.12.1397","volume":"17","author":"M Mokan","year":"1994","unstructured":"Mokan M, Mitrakou A, Veneman T et al (1994) Hypoglycemia unawareness in IDDM. Diabetes Care 17:1397\u20131403. https:\/\/doi.org\/10.2337\/DIACARE.17.12.1397","journal-title":"Diabetes Care"},{"key":"5749_CR50","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.2337\/DIABETES.47.12.1920","volume":"47","author":"CG Fanelli","year":"1998","unstructured":"Fanelli CG, Paramore DS, Hershey T et al (1998) Impact of nocturnal hypoglycemia on hypoglycemic cognitive dysfunction in type 1 diabetes. Diabetes 47:1920\u20131927. https:\/\/doi.org\/10.2337\/DIABETES.47.12.1920","journal-title":"Diabetes"},{"key":"5749_CR51","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1097\/00007890-199807270-00017","volume":"66","author":"C Meyer","year":"1998","unstructured":"Meyer C, Hering BJ, Gro\u00dfmann R et al (1998) Improved glucose counterregulation and autonomic symptoms after intraportal islet transplants alone in patients with long-standing type I diabetes mellitus. Transplantation 66:233\u2013240. https:\/\/doi.org\/10.1097\/00007890-199807270-00017","journal-title":"Transplantation"},{"key":"5749_CR52","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1046\/j.1365-2125.2003.01771.x","volume":"55","author":"KM Oltmanns","year":"2003","unstructured":"Oltmanns KM, Deininger E, Wellhoener P et al (2003) Influence of captopril on symptomatic and hormonal responses to hypoglycaemia in humans. Br J Clin Pharmacol 55:347\u2013353. https:\/\/doi.org\/10.1046\/j.1365-2125.2003.01771.x","journal-title":"Br J Clin Pharmacol"},{"key":"5749_CR53","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1210\/jcem-68-6-1118","volume":"68","author":"D Kerr","year":"1989","unstructured":"Kerr D, Macdonald IA, Tattersali RB (1989) Influence of duration of hypoglycemia on the hormonal counterregulatory response in normal subjects. J Clin Endocrinol Metab 68:1118\u20131122. https:\/\/doi.org\/10.1210\/jcem-68-6-1118","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"5749_CR54","first-page":"58","volume":"26","author":"M Taverna","year":"2000","unstructured":"Taverna M, M\u2019bemba J, Sola A et al (2000) Insufficient adaptation of hypoglycaemic threshold for cognitive impairment in tightly controlled type 1 diabetes. Diabetes Metab 26(1):58\u201364","journal-title":"Diabetes Metab"},{"key":"5749_CR55","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1007\/BF00400601","volume":"38","author":"A Maran","year":"1995","unstructured":"Maran A, Lomas J, Macdonald IA, Amiel SA (1995) Lack of preservation of higher brain function during hypoglycaemia in patients with intensively-treated IDDM. Diabetologia 38:1412\u20131418. https:\/\/doi.org\/10.1007\/BF00400601","journal-title":"Diabetologia"},{"issue":"4","key":"5749_CR56","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/S0009-9236(01)26448-0","volume":"70","author":"E Deininger","year":"2001","unstructured":"Deininger E, Oltmanns KM, Wellhoener P et al (2001) Losartan attenuates symptomatic and hormonal responses to hypoglycemia in humans. Clin Pharmacol Ther 70(4):362\u2013369. https:\/\/doi.org\/10.1016\/S0009-9236(01)26448-0","journal-title":"Clin Pharmacol Ther"},{"key":"5749_CR57","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.2337\/DIAB.39.12.1550","volume":"39","author":"TW Jones","year":"1990","unstructured":"Jones TW, McCarthy G, Tamborlane WV et al (1990) Mild hypoglycemia and impairment of brain stem and cortical evoked potentials in healthy subjects. Diabetes 39:1550\u20131555. https:\/\/doi.org\/10.2337\/DIAB.39.12.1550","journal-title":"Diabetes"},{"key":"5749_CR58","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.2337\/DIACARE.20.8.1293","volume":"20","author":"E George","year":"1997","unstructured":"George E, Marques JL, Harris ND et al (1997) Preservation of physiological responses to hypoglycemia 2 days after antecedent hypoglycemia in patients with IDDM. Diabetes Care 20:1293\u20131298. https:\/\/doi.org\/10.2337\/DIACARE.20.8.1293","journal-title":"Diabetes Care"},{"key":"5749_CR59","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1210\/JCEM.82.6.3993","volume":"82","author":"TW Jones","year":"1997","unstructured":"Jones TW, Borg WP, Borg MA et al (1997) Resistance to neuroglycopenia: an adaptive response during intensive insulin treatment of diabetes. J Clin Endocrinol Metab 82:1713\u20131718. https:\/\/doi.org\/10.1210\/JCEM.82.6.3993","journal-title":"J Clin Endocrinol Metab"},{"key":"5749_CR60","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/S0140-6736(94)91336-6","volume":"344","author":"I Cranston","year":"1994","unstructured":"Cranston I, Lomas J, Amiel SA et al (1994) Restoration of hypoglycaemia awareness in patients with long-duration insulin-dependent diabetes. Lancet 344:283\u2013287. https:\/\/doi.org\/10.1016\/S0140-6736(94)91336-6","journal-title":"Lancet"},{"key":"5749_CR61","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1007\/S001250050910","volume":"41","author":"K Kanc","year":"1998","unstructured":"Kanc K, Janssen MMJ, Keulen ETP et al (1998) Substitution of night-time continuous subcutaneous insulin infusion therapy for bedtime NPH insulin in a multiple injection regimen improves counterregulatory hormonal responses and warning symptoms of hypoglycaemia in IDDM. Diabetologia 41:322\u2013329. https:\/\/doi.org\/10.1007\/S001250050910","journal-title":"Diabetologia"},{"key":"5749_CR62","doi-asserted-by":"publisher","first-page":"790","DOI":"10.2337\/DIABETES.51.3.790","volume":"51","author":"BE De Galan","year":"2002","unstructured":"De Galan BE, Tack CJ, Lenders JW et al (2002) Theophylline improves hypoglycemia unawareness in type 1 diabetes. Diabetes 51:790\u2013796. https:\/\/doi.org\/10.2337\/DIABETES.51.3.790","journal-title":"Diabetes"},{"key":"5749_CR63","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1210\/JCEM.79.5.7962332","volume":"79","author":"BT Kinsley","year":"1994","unstructured":"Kinsley BT, Widom B, Utzschneider K, Simonson DC (1994) Stimulus specificity of defects in counterregulatory hormone secretion in insulin-dependent diabetes mellitus: effect of glycemic control. J Clin Endocrinol Metab 79:1383\u20131389. https:\/\/doi.org\/10.1210\/JCEM.79.5.7962332","journal-title":"J Clin Endocrinol Metab"},{"key":"5749_CR64","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.2337\/DIABETES.47.9.1472","volume":"47","author":"F Ovalle","year":"1998","unstructured":"Ovalle F, Fanelli CG, Paramore DS et al (1998) Brief twice-weekly episodes of hypoglycemia reduce detection of clinical hypoglycemia in type 1 diabetes mellitus. Diabetes 47:1472\u20131479. https:\/\/doi.org\/10.2337\/DIABETES.47.9.1472","journal-title":"Diabetes"},{"key":"5749_CR65","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1056\/nejm198806093182302","volume":"318","author":"PJ Boyle","year":"1988","unstructured":"Boyle PJ, Schwartz NS, Shah SD et al (1988) Plasma Glucose Concentrations at the Onset of Hypoglycemic Symptoms in Patients with Poorly Controlled Diabetes and in Nondiabetics. N Engl J Med 318:1487\u20131492. https:\/\/doi.org\/10.1056\/nejm198806093182302","journal-title":"N Engl J Med"},{"key":"5749_CR66","doi-asserted-by":"publisher","first-page":"4063","DOI":"10.2337\/dc13-1004","volume":"36","author":"L Leelarathna","year":"2013","unstructured":"Leelarathna L, Little SA, Walkinshaw E et al (2013) Restoration of self-awareness of hypoglycemia in adultswith long-standing type 1 diabetes: Hyperinsulinemic-hypoglycemic clamp substudy results from the HypoCOMPaSS trial. Diabetes Care 36:4063\u20134070. https:\/\/doi.org\/10.2337\/dc13-1004","journal-title":"Diabetes Care"},{"key":"5749_CR67","doi-asserted-by":"publisher","first-page":"2764","DOI":"10.2337\/DB16-1478","volume":"66","author":"M Carey","year":"2017","unstructured":"Carey M, Gospin R, Goyal A et al (2017) Opioid Receptor Activation Impairs Hypoglycemic Counterregulation in Humans. Diabetes 66:2764\u20132773. https:\/\/doi.org\/10.2337\/DB16-1478","journal-title":"Diabetes"},{"key":"5749_CR68","doi-asserted-by":"publisher","first-page":"107","DOI":"10.2337\/diacare.25.1.107","volume":"25","author":"EWMT ter Braak","year":"2002","unstructured":"ter Braak EWMT, Appelman AMMF, van der Tweel I et al (2002) The sulfonylurea glyburide induces impairment of glucagon and growth hormone responses during mild insulin-induced hypoglycemia. Diabetes Care 25:107\u2013112. https:\/\/doi.org\/10.2337\/diacare.25.1.107","journal-title":"Diabetes Care"},{"key":"5749_CR69","doi-asserted-by":"publisher","first-page":"609","DOI":"10.2337\/DIABETES.54.3.609","volume":"54","author":"I Gabriely","year":"2005","unstructured":"Gabriely I, Shamoon H (2005) Fructose normalizes specific counterregulatory responses to hypoglycemia in patients with type 1 diabetes. Diabetes 54:609\u2013616. https:\/\/doi.org\/10.2337\/DIABETES.54.3.609","journal-title":"Diabetes"},{"key":"5749_CR70","doi-asserted-by":"publisher","first-page":"365","DOI":"10.4093\/dmj.2016.40.5.365","volume":"40","author":"HS Kim","year":"2016","unstructured":"Kim HS (2016) Blood glucose measurement: Is serum equal to plasma? Diabetes Metab J 40:365\u2013366. https:\/\/doi.org\/10.4093\/dmj.2016.40.5.365","journal-title":"Diabetes Metab J"},{"issue":"38","key":"5749_CR71","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S41241-018-0067-7","volume":"381","author":"AS Rodrigues","year":"2018","unstructured":"Rodrigues AS, Calsavara VF, Silva FIB et al (2018) Use of interval-censored survival data as an alternative to Kaplan-Meier survival curves: studies of oral lesion occurrence in liver transplants and cancer recurrence. Appl Cancer Res 381(38):1\u201310. https:\/\/doi.org\/10.1186\/S41241-018-0067-7","journal-title":"Appl Cancer Res"},{"key":"5749_CR72","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1210\/jcem-51-4-877","volume":"51","author":"JV Santiago","year":"1980","unstructured":"Santiago JV, Clarke WL, Shah SD, Cryer PE (1980) Epinephrine, norepinephrine, glucagon, and growth hormone release in association with physiological decrements in the plasma glucose concentration in normal and diabetic man. J Clin Endocrinol Metab 51:877\u2013883. https:\/\/doi.org\/10.1210\/jcem-51-4-877","journal-title":"J Clin Endocrinol Metab"},{"key":"5749_CR73","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.peptides.2017.12.001","volume":"100","author":"GLC Yosten","year":"2018","unstructured":"Yosten GLC (2018) Alpha cell dysfunction in type 1 diabetes. Peptides 100:54\u201360. https:\/\/doi.org\/10.1016\/j.peptides.2017.12.001","journal-title":"Peptides"},{"key":"5749_CR74","doi-asserted-by":"publisher","first-page":"134","DOI":"10.2337\/diab.32.2.134","volume":"32","author":"G Bolli","year":"1983","unstructured":"Bolli G, de Feo P, Compagnucci P et al (1983) Abnormal glucose counterregulation in insulin-dependent diabetes mellitus. Interaction of anti-insulin antibodies and impaired glucagon and epinephrine secretion. Diabetes 32:134\u2013141. https:\/\/doi.org\/10.2337\/diab.32.2.134","journal-title":"Diabetes"},{"key":"5749_CR75","doi-asserted-by":"publisher","first-page":"517","DOI":"10.7326\/0003-4819-128-7-199804010-00001","volume":"128","author":"Group TDR","year":"1998","unstructured":"Group TDR (1998) Effect of intensive therapy on residual \u03b2-cell function in patients with type 1 diabetes in the diabetes control and complications trial: A randomized, controlled trial. Ann Intern Med 128:517\u2013523. https:\/\/doi.org\/10.7326\/0003-4819-128-7-199804010-00001","journal-title":"Ann Intern Med"},{"key":"5749_CR76","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/BF00402539","volume":"35","author":"J Hilsted","year":"1992","unstructured":"Hilsted J, Christensen NJ (1992) Dual effect of insulin on plasma volume and transcapillary albumin transport. Diabetologia 35:99\u2013103. https:\/\/doi.org\/10.1007\/BF00402539","journal-title":"Diabetologia"},{"key":"5749_CR77","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.2337\/diacare.28.5.1245","volume":"28","author":"Workgroup on Hypoglycemia, American Diabetes Association","year":"2005","unstructured":"Workgroup on Hypoglycemia, American Diabetes Association (2005) Defining and reporting hypoglycemia in diabetes: a report from the American Diabetes Association Workgroup on Hypoglycemia. Diabetes Care 28:1245\u20131249. https:\/\/doi.org\/10.2337\/diacare.28.5.1245","journal-title":"Diabetes Care"},{"key":"5749_CR78","doi-asserted-by":"publisher","first-page":"155","DOI":"10.2337\/dc16-2215","volume":"40","author":"IHSG","year":"2017","unstructured":"IHSG (2017) Glucose concentrations of less than 3.0 mmol\/L (54 mg\/dL) should be reported in clinical trials: A joint position statement of the American diabetes association and the European association for the study of diabetes. Diabetes Care 40:155\u2013157. https:\/\/doi.org\/10.2337\/dc16-2215","journal-title":"Diabetes Care"}],"container-title":["Diabetologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-022-05749-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00125-022-05749-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-022-05749-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,15]],"date-time":"2022-09-15T07:04:27Z","timestamp":1663225467000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00125-022-05749-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,22]]},"references-count":78,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["5749"],"URL":"https:\/\/doi.org\/10.1007\/s00125-022-05749-8","relation":{},"ISSN":["0012-186X","1432-0428"],"issn-type":[{"value":"0012-186X","type":"print"},{"value":"1432-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,22]]},"assertion":[{"value":"25 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}